Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 681,110 | 676,844 | 730,288 | 680,800 | 691,099 |
| Cost of Goods | 318,627 | 314,427 | 333,191 | 308,233 | 296,068 |
| Gross Profit | 362,483 | 362,417 | 397,097 | 372,567 | 395,031 |
| Operating Expenses | 273,493 | 300,931 | 278,618 | 278,154 | 272,207 |
| Operating Income | 89,617 | 61,913 | 118,670 | 94,646 | 122,892 |
| Interest Expense | 12,343 | 12,337 | 11,683 | 11,663 | 10,720 |
| Other Income | -1,577,701 | 35,253 | 984,295 | -290,301 | -1,332,377 |
| Pre-tax Income | -1,500,427 | 84,829 | 1,091,282 | -207,318 | -1,220,205 |
| Income Tax | -338,176 | 15,867 | 263,548 | -44,510 | -295,091 |
| Net Income Continuous | -1,162,251 | 68,962 | 827,734 | -162,808 | -925,114 |
| Net Income | $-1,162,251 | $68,962 | $827,734 | $-162,808 | $-925,114 |
| EPS Basic Total Ops | -39.59 | 2.33 | 27.24 | -5.48 | -31.05 |
| EPS Basic Continuous Ops | -39.59 | 2.33 | 27.23 | -5.48 | -31.05 |
| EPS Diluted Total Ops | -39.59 | 2.32 | 27.24 | -5.48 | -31.05 |
| EPS Diluted Continuous Ops | -39.59 | 2.32 | 27.23 | -5.48 | -31.05 |
| EPS Diluted Before Non-Recurring Items | 3.00 | 3.34 | 3.31 | N/A | N/A |
| EBITDA(a) | $89,617 | $61,913 | $118,670 | $94,646 | $122,892 |